Protagonist Therapeutics Inc. logo

Protagonist Therapeutics Inc. (PTGX)

Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
140. 91
+8.89
+6.7338%
$
8.44B Market Cap
- P/E Ratio
- Div Yield
519,100 Volume
0.75 Eps
$ 132.02
Previous Close
Add Transaction
Day Range
131.37 141.08
Year Range
50.48 141.1
Want to track PTGX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Protagonist Therapeutics Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
RN
Ron New Whipplewood Advisors LLC
22 $2,319 $3,023.68 $704.68 30.39%
Cache Advisors LLC
Cache Advisors LLC Cache Advisors LLC
10,143 $468,067.11 $1.42M $950,989.3 203.17%
BM
Berkeley Meredith Hughes Financial Services LLC
6 $596.33 $832.62 $236.29 39.62%
DN
Daniel Newman Noble Wealth Management PBC
8 $981 $1,110.16 $129.16 13.17%
RFL
Rossby Financial LLC Rossby Financial LLC
9 $933 $1,246.09 $313.09 33.56%
GFM
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.
1,404 $68,702.29 $193,941.54 $125,239.25 182.29%
JCB
John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH
105,514 $7.15M $14.58M $7.43M 103.89%
KGL
Kilter Group LLC Kilter Group LLC
4 $222 $553.1 $331.1 149.14%
Nicole Reese
Nicole Reese WPG Advisers LLC
97 $5,933.44 $13,396.18 $7,462.74 125.77%